Arushi Varshney

Arushi Varshney

Auto-generated profile, based on publicly available information

Arushi Varshney

Gilbert S. Omenn Dept. of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JCJi Chen
Ji Chen
CSCassandra N. Spracklen
Cassandra N. Spracklen
GMGaëlle Marenne
Gaëlle Marenne
AVArushi Varshney
Arushi Varshney
LCLaura Corbin
Laura Corbin
KDKo van Willems van Dijk
Ko van Willems van Dijk

13 February 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AVArushi Varshney
Arushi Varshney
LSLaura J. Scott
Laura J. Scott
RWRyan P. Welch
Ryan P. Welch
MEMichael R. Erdos
Michael R. Erdos
PCPeter S. Chines
Peter S. Chines
AYAlice C. Young
Alice C. Young
Genome-wide association studies (GWAS) have identified >100 independent SNPs that modulate the risk of type 2 diabetes (T2D) and related traits. However, the pathogenic mechanisms of most of these SNPs remain elusive. Here, we examined genomic, epigenomic, and transcriptomic profiles in human pancreatic islets to understand the links between genetic variation, chromatin landscape, and gene expression in the context of T2D. We first integrated genome and transcriptome variation across 112 islet samples to produce dense cis-expression quantitative trait loci (cis-eQTL) maps. Additional integration with chromatin-state maps for islets and other diverse tissue types revealed that cis-eQTLs for islet-specific genes are specifically and significantly enriched in islet stretch enhancers. High-resolution chromatin accessibility profiling using assay for transposase-accessible chromatin sequencing (ATAC-seq) in two islet samples enabled us to identify specific transcription factor (TF) footprints embedded in active regulatory elements, which are highly enriched for islet cis-eQTL. Aggregate allelic bias signatures in TF footprints enabled us de novo to reconstruct TF binding affinities genetically, which support the high-quality nature of the TF footprint predictions. Interestingly, we found that T2D GWAS loci were strikingly and specifically enriched in islet Regulatory Factor X (RFX) footprints. Remarkably, within and across independent loci, T2D risk alleles that overlap with RFX footprints uniformly disrupt the RFX motifs at high-information content positions. Together, these results suggest that common regulatory variations have shaped islet TF footprints and the transcriptome and that a confluent RFX regulatory grammar plays a significant role in the genetic component of T2D predisposition. Significance The majority of genetic variants associated with type 2 diabetes (T2D) are located outside of genes in noncoding regions that may regulate gene expression in disease-relevant tissues, like pancreatic islets. Here, we present the largest integrated analysis to date of high-resolution, high-throughput human islet molecular profiling data to characterize the genome (DNA), epigenome (DNA packaging), and transcriptome (gene expression). We find that T2D genetic variants are enriched in regions of the genome where transcription Regulatory Factor X (RFX) is predicted to bind in an islet-specific manner. Genetic variants that increase T2D risk are predicted to disrupt RFX binding, providing a molecular mechanism to explain how the genome can influence the epigenome, modulating gene expression and ultimately T2D risk.

1 October 2017 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
SPSettimio Pacelli
Settimio Pacelli
SBSayantani Basu
Sayantani Basu
JWJonathan Whitlow
Jonathan Whitlow
ACAparna Chakravarti
Aparna Chakravarti
FAFrancisca Acosta
Francisca Acosta
Arghya PaulArghya Paul
Arghya Paul

30 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
AVAna Viñuela
Ana Viñuela
AVArushi Varshney
Arushi Varshney
MBMartijn van de Bunt
Martijn van de Bunt
RBRashmi Prasad B
Rashmi Prasad B
OAOlof Asplund
Olof Asplund
MMMark I. McCarthy
Mark I. McCarthy
Most signals detected by genome-wide association studies map to non-coding sequence and their tissue-specific effects influence transcriptional regulation. However, key tissues and cell-types required for functional inference are absent from large-scale resources. Here we explore the relationship between genetic variants influencing predisposition to type 2 diabetes (T2D) and related glycemic traits, and human pancreatic islet transcription using data from 420 donors. We find: (a) 7741 cis-eQTLs in islets with a replication rate across 44 GTEx tissues between 40% and 73%; (b) marked overlap between islet cis-eQTL signals and active regulatory sequences in islets, with reduced eQTL effect size observed in the stretch enhancers most strongly implicated in GWAS signal location; (c) enrichment of islet cis-eQTL signals with T2D risk variants identified in genome-wide association studies; and (d) colocalization between 47 islet cis-eQTLs and variants influencing T2D or glycemic traits, including DGKB and TCF7L2. Our findings illustrate the advantages of performing functional and regulatory studies in disease relevant tissues.

1 January 2019 in Cell Reports
Verified
Journal Article
Open access
NLNathan Lawlor
Nathan Lawlor
EMEladio J. Márquez
Eladio J. Márquez
POPeter Orchard
Peter Orchard
NNNarisu Narisu
Narisu Narisu
MSMuhammad Saad Shamim
Muhammad Saad Shamim
MSMichael L. Stitzel
Michael L. Stitzel
EndoC-βH1 is emerging as a critical human β cell model to study the genetic and environmental etiologies of β cell (dys)function and diabetes. Comprehensive knowledge of its molecular landscape is lacking, yet required, for effective use of this model. Here, we report chromosomal (spectral karyotyping), genetic (genotyping), epigenomic (ChIP-seq and ATAC-seq), chromatin interaction (Hi-C and Pol2 ChIA-PET), and transcriptomic (RNA-seq and miRNA-seq) maps of EndoC-βH1. Analyses of these maps define known (e.g., PDX1 and ISL1) and putative (e.g., PCSK1 and mir-375) β cell-specific transcriptional cis-regulatory networks and identify allelic effects on cis-regulatory element use. Importantly, comparison with maps generated in primary human islets and/or β cells indicates preservation of chromatin looping but also highlights chromosomal aberrations and fetal genomic signatures in EndoC-βH1. Together, these maps, and a web application we created for their exploration, provide important tools for the design of experiments to probe and manipulate the genetic programs governing β cell identity and (dys)function in diabetes.

9 November 2015 in Genes
Verified
Journal Article
Open access
PDF file
ANAdrienne R. Niederriter
Adrienne R. Niederriter
AVArushi Varshney
Arushi Varshney
SPSteve Parker
Steve Parker
DMDonna Martin
Donna Martin
Recently, unique areas of transcriptional regulation termed super-enhancers have been identified and implicated in human disease. Defined by their magnitude of size, transcription factor density, and binding of transcriptional machinery, super-enhancers have been associated with genes driving cell differentiation. While their functions are not completely understood, it is clear that these regions driving high-level transcription are susceptible to perturbation, and trait-associated single nucleotide polymorphisms (SNPs) occur within super-enhancers of disease-relevant cell types. Here we review evidence for super-enhancer involvement in cancers, complex diseases, and developmental disorders and discuss interactions between super-enhancers and cofactors/chromatin regulators.